...
首页> 外文期刊>Scientific reports. >Diagnostic and clinical utility of whole genome sequencing in a cohort of undiagnosed Chinese families with rare diseases
【24h】

Diagnostic and clinical utility of whole genome sequencing in a cohort of undiagnosed Chinese families with rare diseases

机译:稀有疾病联未认可的中国家庭队列全基因组测序的诊断与临床效用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Rare diseases are usually chronically debilitating or even life-threatening with diagnostic and therapeutic challenges in current clinical practice. It has been estimated that 80% of rare diseases are genetic in origin, and thus genome sequencing-based diagnosis offers a promising alternative for rare-disease management. In this study, 79 individuals from 16 independent families were performed for whole-genome sequencing (WGS) in an effort to identify the causative mutations for 16 distinct rare diseases that are largely clinically intractable. Comprehensive analysis of variations, including simple nucleotide variants (SNVs), copy-number variations (CNVs), and structural variations (SVs), was implemented using the WGS data. A flexible analysis pipeline that allowed a certain degree of misclassification of disease status was developed to facilitate the identification of causative variants. As a result, disease-causing variants were identified in 10 of the 16 investigated diseases, yielding a diagnostic rate of 62.5%. Additionally, new potentially pathogenic variants were discovered for two disorders, including IGF2/INS-IGF2 in mitochondrial disease and FBN3 in Klippel-Trenaunay-Weber syndrome. Our WGS analysis not only detected a CNV associated with 3p deletion syndrome but also captured a simple sequence repeat (SSR) variation associated with Machado-Joseph disease. To our knowledge, this is the first time the?clinical WGS analysis of short-read sequences?has been used successfully to identify a causative SSR variation that perfectly segregates with a repeat expansion disorder. After the WGS analysis, we confirmed the initial diagnosis for three of 10 established disorders and modified or corrected the initial diagnosis for the remaining seven disorders. In summary, clinical WGS is a powerful tool for the diagnosis of rare diseases, and its diagnostic clarity at molecular levels offers important benefits for the participating families.
机译:罕见的疾病通常是长期衰弱的甚至甚至威胁到当前临床实践中的诊断和治疗挑战。据估计,80%的罕见疾病是原产地的遗传,因此基于基因组测序的诊断为稀有疾病管理提供了有希望的替代品。在本研究中,针对全基因组测序(WGS)进行来自16个独立家族的79个个体,以判断16种不同初始疾病的致病性突变,这在很大程度上是临床难治性的。使用WGS数据实现综合分析变异,包括简单的核苷酸变体(SNV),复制数变体(CNV)和结构变体(SV)。开发了一种允许一定程度的疾病状态错误分类的柔性分析管道,以便于鉴定致病变体。结果,在16种研究疾病的10个中鉴定了疾病的变异,产生了62.5%的诊断率。另外,对于两种疾病发现了新的潜在致病变体,包括线粒体疾病中的IGF2 / INS-IGF2和KLIPPEL-TRENANAIN-WEBER综合征中的FBN3。我们的WGS分析不仅检测到与3P删除综合征相关的CNV,而且还捕获了与Machado-Joseph疾病相关的简单序列重复(SSR)变异。为了我们的知识,这是第一次?临床WGS对短读序列的分析?已成功用于识别出于重复膨胀障碍的完美偏离的致病性SSR变化。在WGS分析后,我们确认了10名既定疾病中三种的初步诊断,并修改或纠正了剩余的七种疾病的初步诊断。总之,临床WG是诊断稀有疾病的强大工具,其分子水平的诊断清晰度为参与家属提供了重要的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号